As on Thursday, Context Therapeutics Inc (NASDAQ: CNTX) got off with the flyer as it spiked 9.15% to $1.79, before settling in for the price of $1.64 at the close. Taking a more long-term approach, CNTX posted a 52-week range of $0.49-$2.00.
The Healthcare sector firm’s twelve-monthly sales growth has been 4.72% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 4.72%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 24.13%. This publicly-traded company’s shares outstanding now amounts to $91.88 million, simultaneously with a float of $61.00 million. The organization now has a market capitalization sitting at $164.46 million.
Context Therapeutics Inc (CNTX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Context Therapeutics Inc’s current insider ownership accounts for 33.61%, in contrast to 43.09% institutional ownership. According to the most recent insider trade that took place on Jun 09 ’25, this organization’s Chief Executive Officer bought 100,000 shares at the rate of 0.70, making the entire transaction reach 70,080 in total value, affecting insider ownership by 920,190. Preceding that transaction, on Jun 06 ’25, Company’s Chief Legal Officer, Corp. Sec bought 20,000 for 0.58, making the whole transaction’s value amount to 11,520. This particular insider is now the holder of 29,000 in total.
Context Therapeutics Inc (CNTX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
Context Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 24.13% and is forecasted to reach -0.41 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 4.76% through the next 5 years, which can be compared against the 4.72% growth it accomplished over the previous five years trading on the market.
Context Therapeutics Inc (NASDAQ: CNTX) Trading Performance Indicators
Let’s observe the current performance indicators for Context Therapeutics Inc (CNTX). It’s Quick Ratio in the last reported quarter now stands at 13.07.
In the same vein, CNTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.28, a figure that is expected to reach -0.10 in the next quarter, and analysts are predicting that it will be -0.41 at the market close of one year from today.
